IL6 and neoplasm: In addition to preventing primary T-cell activation, MDSCs secret IL-6 to attenuate functional differentiation of the tumor-specific cluster of differentiation 4+ (CD4+) T cells into effector Th1 cells and promote tumor progression [50].